Published in J Mol Endocrinol on February 16, 2009
Novel insights on thyroid-stimulating hormone receptor signal transduction. Endocr Rev (2013) 0.97
Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies. J Peripher Nerv Syst (2013) 0.91
Thyrotropin (TSH) receptor residue E251 in the extracellular leucine-rich repeat domain is critical for linking TSH binding to receptor activation. Endocrinology (2010) 0.85
Targeting the thyroid-stimulating hormone receptor with small molecule ligands and antibodies. Expert Opin Ther Targets (2015) 0.83
Probing structural variability at the N terminus of the TSH receptor with a murine monoclonal antibody that distinguishes between two receptor conformational forms. Endocrinology (2012) 0.81
Allosteric modulators hit the TSH receptor. Endocrinology (2014) 0.80
Novel information on the epitope of an inverse agonist monoclonal antibody provides insight into the structure of the TSH receptor. PLoS One (2012) 0.79
Antibody protection reveals extended epitopes on the human TSH receptor. PLoS One (2012) 0.79
Blocking type TSH receptor antibodies. Auto Immun Highlights (2012) 0.77
The hinge region of human thyroid-stimulating hormone (TSH) receptor operates as a tunable switch between hormone binding and receptor activation. PLoS One (2012) 0.77
In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1-70). Auto Immun Highlights (2011) 0.76
A ligase-mediated gene detection technique. Science (1988) 7.61
Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med (2001) 5.29
Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol (2000) 4.58
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42
Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood (1996) 2.19
Human monoclonal thyroid stimulating autoantibody. Lancet (2003) 2.15
Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group. Blood (1996) 2.12
Autoantibodies to the thyrotropin receptor. Endocr Rev (1988) 2.02
Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol (2001) 1.96
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia. J Clin Oncol (2000) 1.92
Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease. Proc Natl Acad Sci U S A (2002) 1.87
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood (1995) 1.79
Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist. Thyroid (2005) 1.76
Long-term outcome after marrow transplantation for severe aplastic anemia. Blood (1998) 1.63
Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab (2011) 1.60
Fetal growth and autoimmune thyroid disease. Q J Med (1993) 1.53
A randomised controlled trial of flexibility in routine antenatal care. BJOG (2000) 1.52
Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases. Clin Chem (1995) 1.51
Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol (1995) 1.50
Cloning of a human autoimmune response: preparation and sequencing of a human anti-thyroglobulin autoantibody using a combinatorial approach. Autoimmunity (1992) 1.47
Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation. Br J Haematol (1996) 1.47
Implantable venous access devices in children with hemophilia: a report of low infection rates. J Pediatr (1998) 1.40
Intensively timed induction therapy followed by autologous or allogeneic bone marrow transplantation for children with acute myeloid leukemia or myelodysplastic syndrome: a Childrens Cancer Group pilot study. J Clin Oncol (1993) 1.37
A receptor assay for the measurement of TSH receptor antibodies in unextracted serum. Clin Endocrinol (Oxf) (1984) 1.36
Donor origin of the in vitro haematopoietic microenvironment after marrow transplantation in man. Nature (1982) 1.35
The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol (1984) 1.34
Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. EMBO J (2001) 1.28
Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid (2004) 1.28
Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant (1988) 1.27
Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood (1996) 1.26
The IgG subclass distribution of thyroglobulin antibody synthesized in culture. Scand J Immunol (1983) 1.16
Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood (1999) 1.14
Efficacy of perioperative halo-gravity traction in the treatment of severe scoliosis in children. J Pediatr Orthop (2001) 1.14
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers. Biol Blood Marrow Transplant (2001) 1.13
Pilot study of high-dose thiotepa and etoposide with autologous bone marrow rescue in children and young adults with recurrent CNS tumors. The Children's Cancer Group. J Clin Oncol (1996) 1.13
The dnaB-pheA (256 degrees-240 degrees) region of the Bacillus subtilis chromosome containing genes responsible for stress responses, the utilization of plant cell walls and primary metabolism. Microbiology (1996) 1.13
IgG subclass distribution of thyroid autoantibodies: a 'fingerprint' of an individual's response to thyroglobulin and thyroid microsomal antigen. Clin Endocrinol (Oxf) (1987) 1.11
I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab (1997) 1.10
Salmonella enteritidis in eggs from commercial chicken layer flocks implicated in human outbreaks. Avian Dis (1994) 1.10
Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml. J Urol (2000) 1.08
Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. Blood (1986) 1.07
Alpha adrenergic and histaminergic effects of tolazoline-like imidazolines. J Pharmacol Exp Ther (1975) 1.06
Eye signs of graves' disease and blocking-type thyrotropin receptor autoantibodies. Thyroid (2006) 1.06
TSH receptor antibody synthesis by thyroid lymphocytes. Clin Endocrinol (Oxf) (1986) 1.03
Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet (1982) 1.03
Skin response to repetitive mechanical stress: a new experimental model in pig. Arch Phys Med Rehabil (1998) 1.02
Thyroid autoantibody synthesis by lymphocytes from different lymphoid organs: fractionation of B cells on density gradients. Immunology (1985) 1.02
Characterization of TSH antagonist activity in the serum of patients with thyroid disease. Clin Endocrinol (Oxf) (1986) 1.01
Labelling and immunoprecipitation of thyroid microsomal antigen. FEBS Lett (1985) 1.01
Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine. Am J Med (1985) 1.00
Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anaemia. Br J Haematol (2005) 1.00
Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis). Blood (1998) 1.00
Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplant (1998) 0.99
Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab (1996) 0.98
II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab (1997) 0.98
A structural comparison of guinea pig thyroid and fat TSH receptors by photoaffinity labelling. FEBS Lett (1984) 0.98
Glutamic acid decarboxylase autoantibody assay using 125I-labelled recombinant GAD65 produced in yeast. Clin Chim Acta (1996) 0.96
Retinotopic organization of human visual cortex: departures from the classical model. Cereb Cortex (1996) 0.96
The views and anticipated needs of women in early pregnancy. BJOG (2000) 0.96
Severe combined immunodeficient (SCID) mice: a model for investigating human thyroid autoantibody synthesis. Clin Exp Immunol (1991) 0.95
Enrichment and depletion of thyroglobulin autoantibody synthesizing lymphocytes. Clin Exp Immunol (1983) 0.95
Methods for assessment of graft-versus-host disease. Blood (1998) 0.95
The geographical distribution of thyrotoxicosis in England according to the presence or absence of TSH-receptor antibodies. Clin Endocrinol (Oxf) (1985) 0.95
Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era. Leukemia (2005) 0.95
Anterior cerebral artery reconstruction. Neurosurgery (1986) 0.94
Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Heart (2002) 0.94
The myelin proteins of the shark brain are similar to the myelin proteins of the mammalian peripheral nervous system. J Mol Evol (1989) 0.93
Domiciliary midwifery support in high-risk pregnancy incorporating telephonic fetal heart rate monitoring: a health technology randomized assessment. J Telemed Telecare (1999) 0.93
Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood (1990) 0.93
Acute lymphoblastic leukaemia after bone marrow transplantation for aplastic anaemia. Br J Haematol (1986) 0.93
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial. Int J Radiat Oncol Biol Phys (1995) 0.93
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation. Bone Marrow Transplant (1987) 0.92
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia. Bone Marrow Transplant (1994) 0.92
Cloning and characterisation of TPO autoantibodies using combinatorial phage display libraries. Autoimmunity (1994) 0.91
Standard haemostatic tests following major obstetric haemorrhage. Int J Obstet Anesth (2011) 0.91
Thyroid autoantigens and human T cell responses. Clin Exp Immunol (1990) 0.91
Is there a case for the early use of bisphosphonates in smouldering myeloma and MGUS? (Bisphosphonates in SMM & MGUS). Int J Lab Hematol (2007) 0.91
Characterization of lymphoid cells in the thyroid of patients with Graves' disease. Clin Exp Immunol (1984) 0.91
Acute renal failure following cardiac operations. J Thorac Cardiovasc Surg (1980) 0.91
Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood (1982) 0.90
Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant (1992) 0.90
Subpopulations of thyroid autoantibody secreting lymphocytes in Graves' and Hashimoto thyroid glands. Clin Exp Immunol (1986) 0.89
Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung. Cancer Treat Rep (1983) 0.89
Secondary malignancies after marrow transplantation. Exp Hematol (1984) 0.89
Epitope analysis of the human thyrotropin (TSH) receptor using monoclonal antibodies. Thyroid (2000) 0.89
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation. Blood (1986) 0.89